Subacute zinc administration and L-name caused an increase of NO, Zinc, lipoperoxidation, and caspase-3 during a cerebral hypoxia-ischemia process in the rat

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Blanco Alvarez, Victor Manuel ^a   Lopez Moreno, Patricia ^a   Soto Rodriguez, Guadalupe ^a   Martinez Fong, Daniel ^b   Rubio, Hector ^c   Gonzalez Barrios, Juan Antonio ^d   Piña Leyva, Celia ^a   Torres Soto, Maricela ^a   Gomez Villalobos, María De Jesus ^a   Hernandez Baltazar, Daniel ^b   Brambila, Eduardo ^a   Eguibar, José Ramon ^a   Ugarte, Araceli ^a   Cebada, Jorge ^a   Leon Chavez, Bertha Alicia ^a  

^a BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DE YUCATÁN   (Mexico)

^d CENTRO MÉDICO NACIONAL 20 DE NOVIEMBRE   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

EFFECT OF ZINCS; HYPOXIA-ISCHEMIA; IMMUNOSTAINING; INTRAPERITONEAL INJECTIONS; LIPOPEROXIDATION; NITROSATIVE STRESS; THERAPEUTIC STRATEGY; WISTAR RAT;

AMINO ACIDS; CELL DEATH; NITROGEN COMPOUNDS;

ZINC;

CASPASE 3; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; ZINC; ZINC CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD PRESSURE; CELL DEATH; CELL STRUCTURE; CHOROID PLEXUS; CONTROLLED STUDY; DENTATE GYRUS; HIPPOCAMPUS; HISTOPATHOLOGY; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIPID PEROXIDATION; MALE; NECROSIS; NITROSATIVE STRESS; NONHUMAN; PARIETAL CORTEX; PROTEIN EXPRESSION; RAT; REPERFUSION; SYSTOLIC BLOOD PRESSURE; ANIMAL; COMMON CAROTID ARTERY; DRUG EFFECT; METABOLISM; OXIDATIVE STRESS; WISTAR RAT; DRUG EFFECTS;

ANIMALS; CAROTID ARTERY, COMMON; CASPASE 3; HYPOXIA-ISCHEMIA, BRAIN; LIPID PEROXIDATION; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RATS, WISTAR; ZINC;

EID: 84883175343     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/240560     Document Type: Article

References (53)

1. Dávalos A., Thrombolysis in acute ischemic stroke: successes, failures, and new hopes. Cerebrovascular Diseases 2005 20 supplement 2 135 139 2-s2.0-33644814459 10.1159/000089367
2. Matsushita K., Kitagawa K., Matsuyama T., Ohtsuki T., Taguchi A., Mandai K., Mabuchi T., Yagita Y., Yanagihara T., Matsumoto M., Effect of systemic zinc administration on delayed neuronal death in the gerbil hippocampus. Brain Research 1996 743 1-2 362 365 2-s2.0-17444437198 10.1016/S0006-8993(96)01112-2
3. Kitamura Y., Iida Y., Abe J., Ueda M., Mifune M., Kasuya F., Ohta M., Igarashi K., Saito Y., Saji H., Protective effect of zinc against ischemic neuronal injury in a middle cerebral artery occlusion model. Journal of Pharmacological Sciences 2006 100 2 142 148 2-s2.0-33244455199 10.1254/jphs.FP0050805
4. Zhao Y.-J., Yang G.-Y., Domino E. F., Zinc protoporphyrin, zinc ion, and protoporphyrin reduce focal cerebral ischemia. Stroke 1996 27 12 2299 2303 2-s2.0-0030482413
5. 2+ during the reperfusion phase of transient cerebral ischaemia protects rat hippocampus against iron-catalysed postischaemic injury. Clinical and Experimental Pharmacology and Physiology 2008 35 7 775 781 2-s2.0-44349107651 10.1111/j.1440-1681.2007.04858.x
6. Tonder B., Johansen F. F., Frederickson C. J., Zimmer J., Diemer N. H., Possible role of zinc in the selective degeneration of dentate hilar neurons after cerebral ischemia in the adult rat. Neuroscience Letters 1990 109 3 247 252 2-s2.0-0025138527 10.1016/0304-3940(90)90002-Q
7. Koh J.-Y., Suh S. W., Gwag B. J., He Y. Y., Hsu C. Y., Choi D. W., The role of zinc in selective neuronal death after transient global cerebral ischemia. Science 1996 272 5264 1013 1016 2-s2.0-0029777299
8. Lees G. J., Lehmann A., Sandberg M., Hamberger A., The neurotoxicity of zinc in the rat hippocampus. Neuroscience Letters 1990 120 2 155 158 2-s2.0-0025696254 10.1016/0304-3940(90)90026-6
9. Shabanzadeh A. P., Shuaib A., Yang T., Salam A., Wang C. X., Effect of zinc in ischemic brain injury in an embolic model of stroke in rats. Neuroscience Letters 2004 356 1 69 71 2-s2.0-1642472737 10.1016/j.neulet.2003. 10.073
10. Calderone A., Jover T., Mashiko T., Noh K.-M., Tanaka H., Bennett M. V. L., Zukin R. S., Late calcium EDTA rescues hippocampal CA1 neurons from global ischemia-induced death. Journal of Neuroscience 2004 24 44 9903 9913 2-s2.0-7744222541 10.1523/JNEUROSCI.1713-04.2004
11. 2+: a novel ionic mediator of neural injury in brain disease. Trends in Pharmacological Sciences 2000 21 10 395 401 2-s2.0-0034306057 10.1016/S0165-6147(00)01541-8
12. 2+ permeable AMPA or kainate receptors: possible key factors in selective neurodegeneration. Trends in Neurosciences 2000 23 8 365 371 2-s2.0-0034238089 10.1016/S0166- 2236(00)01610-6
13. Farinati F., Cardin R., D'Inca R., Naccarato R., Sturniolo G. C., Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease. Journal of Laboratory and Clinical Medicine 2003 141 6 372 377 2-s2.0-0038810040 10.1016/S0022-2143(03)00027-1
14. Ganju N., Eastman A., Zinc inhibits Bax and Bac activation and cytochrome c release induced by chemical inducers of apoptosis but not by death-receptor-intiated pathways. Cell Death and Differentiation 2003 10 6 652 661 2-s2.0-0038651008 10.1038/sj.cdd.4401234
15. Perry D. K., Smyth M. J., Stennicke H. R., Salvesen G. S., Duriez P., Poirier G. G., Hannun Y. A., Zinc is a potent inhibitor of the apoptotic protease, caspase-3: a novel target for zinc in the inhibition of apoptosis. Journal of Biological Chemistry 1997 272 30 18530 18533 2-s2.0-0030855488 10.1074/jbc.272.30.18530
16. Truong-Tran A. Q., Carter J., Ruffin R. E., Zalewski P. D., The role of zinc in caspase activation and apoptotic cell death. BioMetals 2001 14 3-4 315 330 2-s2.0-0035693751 10.1023/A:1012993017026
17. Smith A. F., Longpre J., Loo G., Inhibition by zinc of deoxycholate-induced apoptosis in HCT-116 cells. Journal of Cellular Biochemistry 2012 113 2 650 657 2-s2.0-84855533439 10.1002/jcb.23394
18. Aguilar-Alonso P., Martinez-Fong D., Pazos-Salazar N. G., Brambila E., Gonzalez-Barrios J. A., Mejorada A., Flores G., Millan-PerezPeña L., Rubio H., Leon-Chavez B. A., The increase in Zinc levels and upregulation of Zinc transporters are mediated by nitric oxide in the cerebral cortex after transient ischemia in the rat. Brain Research 2008 1200 89 98 2-s2.0-40849130012 10.1016/j.brainres.2007.11.077
19. Frederickson C. J., Cuajungco M. P., LaBuda C. J., Suh S. W., Nitric oxide causes apparent release of zinc from presynaptic boutons. Neuroscience 2002 115 2 471 474 2-s2.0-0037146612 10.1016/S0306-4522(02)00399-8
20. Aravindakumar C. T., Ceulemans J., de Ley M., Nitric oxide induces Zn2+ release from metallothionein by destroying zinc-sulphur clusters without concomitant formation of S-nitrosothiol. Biochemical Journal 1999 344 part 1 253 258 2-s2.0-0033571671 10.1042/0264-6021:3440253
21. Sergent O., Griffon B., Morel I., Chevanne M., Dubos M.-P., Cillard P., Cillard J., Effect of nitric oxide on iron-mediated oxidative stress in primary rat hepatocyte culture. Hepatology 1997 25 1 122 127 2-s2.0-0031012323
22. Guo J. Y., Yang T., Sun X. G., Zhou N. Y., Li F. S., Long D., Lin T., Li P. Y., Feng L., Ischemic postconditioning attenuates liver warm ischemia-reperfusion injury through Akt-eNOS-NO-HIF pathway. Journal of Biomedical Science 2011 18 1, article 79 2-s2.0-80054985592 10.1186/1423-0127- 18-79
23. Mohammadi M. T., Shid-Moosavi S. M., Dehghani G. A., Contribution of nitric oxide synthase (NOS) in blood-brain barrier disruption during acute focal cerebral ischemia in normal rat. Pathophysiology 2012 19 1 13 20 2-s2.0-84857458147 10.1016/j.pathophys.2011.07.003
24. Pinelli A., Trivulzio S., Tomasoni L., Bertolini B., Brenna S., Bonacina E., Low nitric oxide values associated with low levels of zinc and high levels of cardiac necrosis markers detected in the plasma of rabbits treated with L-NAME. Journal of Cardiovascular Pharmacology 2001 37 3 310 316 2-s2.0-0035120344 10.1097/00005344-200103000-00009
25. Soto-Rodriguez G., Martinez-Fong D., Arroyo R., Aguilar-Alonso P., Rubio H., Eguibar J. R., Ugarte A., Torres-Soto M., Gonzalez-Barrios J. A., Cebada J., Brambila E., Leon-Chavez B. A., Nitric oxide production is associated to increased lipoperoxidation and active caspase-3 in demyelinated brain regions of the taiep rat. Advances in Bioscience and Biotechnology 2012 3 6A 695 704
26. Vega E., de Jésus Gómez-Villalobos M., Flores G., Alteration in dendritic morphology of pyramidal neurons from the prefrontal cortex of rats with renovascular hypertension. Brain Research 2004 1021 1 112 118 2-s2.0-4344656956 10.1016/j.brainres.2004.06.042
27. Pavlica S., Gebhardt R., Comparison of uptake and neuroprotective potential of seven zinc-salts. Neurochemistry International 2010 56 1 84 93 2-s2.0-73449091112 10.1016/j.neuint.2009.09.005
28. Morikawa E., Moskowitz M. A., Huang Z., Yoshida T., Irikura K., Dalkara T., L-Arginine infusion promotes nitric oxide-dependent vasodilation, increases regional cerebral blood flow, and reduces infarction volume in the rat. Stroke 1994 25 2 429 435 2-s2.0-0028180199
29. Katakai K., Liu J., Nakajima K., K. Keefer L., P Waalkes M., Nitric oxide induces metallothionein (MT) gene expression apparently by displacing zinc bound to MT. Toxicology Letters 2001 119 2 103 108 2-s2.0-0035961216 10.1016/S0378-4274(00)00301-5
30. Vallee B. L., Introduction to metallothionein. Methods in Enzymology 1991 205 3 7 2-s2.0-0026345446
31. di Naso F. C., Dias A. S., Porawski M., Marroni N. A. P., Exogenous superoxide dismutase: action on liver oxidative stress in animals with streptozotocin-induced diabetes. Experimental Diabetes Research 2011 2011 6 2-s2.0-79955095438 10.1155/2011/754132 754132
32. Kumar S. D., Vijaya M., Samy R. P., Dheen S. T., Ren M., Watt F., Zinc supplementation prevents cardiomyocyte apoptosis and congenital heart defects in embryos of diabetic mice. Free Radical Biology 2012 53 8 1595 1606
33. Hemmens B., Goessler W., Schmidt K., Mayer B., Role of bound zinc in dimer stabilization but not enzyme activity of neuronal nitric-oxide synthase. Journal of Biological Chemistry 2000 275 46 35786 35791 2-s2.0-0034680914 10.1074/jbc.M005976200
34. Li H., Raman C. S., Glaser C. B., Blasko E., Young T. A., Parkinson J. F., Whitlow M., Poulos T. L., Crystal structures of zinc-free and -bound heme domain of human inducible nitric-oxide synthase. Implications for dimer stability and comparison with endothelial nitric-oxide synthase. Journal of Biological Chemistry 1999 274 30 21276 21284 2-s2.0-0033597930 10.1074/jbc.274.30.21276
35. Samdani A. F., Dawson T. M., Dawson V. L., Nitric oxide synthase in models of focal ischemia. Stroke 1997 28 6 1283 1288 2-s2.0-0030988138
36. Ho E., Quan N., Tsai Y.-H., Lai W., Bray T. M., Dietary zinc supplementation inhibits NF B activation and protects against chemically induced diabetes in CD1 mice. Proceedings of the Society for Experimental Biology and Medicine 2001 226 2 103 111 2-s2.0-0035130899
37. Farias M. S., Budni P., Ribeiro C. M., Parisotto E. B., Santos C. E., Dias J. F., Antioxidant supplementation attenuates oxidative stress in chronic hepatitis C patients. Gastroenterology and Hepatology 2012 35 6 386 394
38. Thambiayya K., Wasserloos K., Kagan V. E., Stoyanovsky D., Pitt B. R., A critical role for increased labile zinc in reducing sensitivity of cultured sheep pulmonary artery endothelial cells to LPS-induced apoptosis. American Journal of Physiology-Lung Cellular and Molecular Physiology 2012 302 12 L1287 L1295
39. Lee J.-Y., Kim Y.-J., Kim T.-Y., Koh J.-Y., Kim Y.-H., Essential role for zinc-triggered p75NTR activation in preconditioning neuroprotection. Journal of Neuroscience 2008 28 43 10919 10927 2-s2.0-58149165235 10.1523/JNEUROSCI.3421- 08.2008
40. Bossy-Wetzel E., Talantova M. V., Lee W. D., Schölzke M. N., Harrop A., Mathews E., Götz T., Han J., Ellisman M. H., Perkins G. A., Lipton S. A., Crosstalk between nitric oxide and zinc pathways to neuronal cell death involving mitochondrial dysfunction and p38-activated K+ channels. Neuron 2004 41 3 351 365 2-s2.0-10744230660 10.1016/S0896-6273(04)00015-7
41. Cuajungco M. P., Lees G. J., Nitric oxide generators produce accumulation of chelatable zinc in hippocampal neuronal perikarya. Brain Research 1998 799 1 118 129 2-s2.0-0032514150 10.1016/S0006-8993(98)00463-6
42. Lees G. J., Cuajungco M. P., Leong W., Effect of metal chelating agents on the direct and seizure-related neuronal death induced by zinc and kainic acid. Brain Research 1998 799 1 108 117 2-s2.0-0032514171 10.1016/S0006-8993(98) 00483-1
43. 2+ during ischemia and reperfusion of hippocampus slices in rat. Neuroscience 2004 125 4 867 877 2-s2.0-2142821384 10.1016/j.neuroscience.2004.03.011
44. Ding-Zhou L., Marchand-Verrecchia C., Croci N., Plotkine M., Margaill I., L-NAME reduces infarction, neurological deficit and blood-brain barrier disruption following cerebral ischemia in mice. European Journal of Pharmacology 2002 457 2-3 137 146 2-s2.0-0037146889 10.1016/S0014-2999(02)02686-9
45. Benter I. F., Yousif M. H. M., Al-Saleh F. M., Raghupathy R., Chappell M. C., Diz D. I., Angiotensin-(1-7) blockade attenuates captopril- or hydralazine-induced cardiovascular protection in spontaneously hypertensive rats treated with NG-nitro-l-arginine methyl ester. Journal of Cardiovascular Pharmacology 2011 57 5 559 567 2-s2.0-79957668948 10.1097/FJC.0b013e31821324b6
46. Niziolek M., Korytowski W., Girotti A. W., Nitric oxide inhibition of free radical-mediated lipid peroxidation in photodynamically treated membranes and cells. Free Radical Biology and Medicine 2003 34 8 997 1005 2-s2.0-0037446374 10.1016/S0891-5849(03)00026-1
47. Sensi S. L., Canzoniero L. M. T., Yu S. P., Ying H. S., Koh J.-Y., Kerchner G. A., Choi D. W., Measurement of intracellular free zinc in living cortical neurons: routes of entry. Journal of Neuroscience 1997 17 24 9554 9564 2-s2.0-0031466709
48. Suh S. W., Frederickson C. J., Danscher G., Neurotoxic zinc translocation into hippocampal neurons is inhibited by hypothermia and is aggravated by hyperthermia after traumatic brain injury in rats. Journal of Cerebral Blood Flow and Metabolism 2006 26 2 161 169 2-s2.0-31444434743 10.1038/sj.jcbfm. 9600176
49. Frederickson C. J., Bush A. I., Synaptically released zinc: physiological functions and pathological effects. BioMetals 2001 14 3-4 353 366 2-s2.0-0035696287 10.1023/A:1012934207456
50. 2+ induces permeability transition pore opening and release of pro-apoptotic peptides from neuronal mitochondria. Journal of Biological Chemistry 2001 276 50 47524 47529 2-s2.0-0035861677 10.1074/jbc.M108834200
51. Manev H., Kharlamov E., Uz T., Mason R. P., Cagnoli C. M., Characterization of zinc-induced neuronal death in primary cultures of rat cerebellar granule cells. Experimental Neurology 1997 146 1 171 178 2-s2.0-0031194657 10.1006/exnr.1997.6510
52. Koh J.-Y., Zinc and disease of the brain. Molecular Neurobiology 2001 24 1-3 99 106 2-s2.0-0035696440
53. Sensi S. L., Paoletti P., Bush A. I., Sekler I., Zinc in the physiology and pathology of the CNS. Nature Reviews Neuroscience 2009 10 11 780 791 2-s2.0-70350220417 10.1038/nrn2734